171 related articles for article (PubMed ID: 21358410)
21. Disclosure to the family of breast/ovarian cancer genetic test results: patient's willingness and associated factors.
Julian-Reynier C; Eisinger F; Chabal F; Lasset C; Noguès C; Stoppa-Lyonnet D; Vennin P; Sobol H
Am J Med Genet; 2000 Sep; 94(1):13-8. PubMed ID: 10982476
[TBL] [Abstract][Full Text] [Related]
22. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
23. Experiences of BRCA1/2 Gene Mutation-Positive Women With Cancer in Communicating Genetic Risk to Their Relatives.
Seven M; Shah LL; Daack-Hirsch S; Yazici H
Cancer Nurs; 2021 May-Jun 01; 44(3):E142-E150. PubMed ID: 32022782
[TBL] [Abstract][Full Text] [Related]
24. Cascade testing for inherited arrhythmia conditions: Experiences and attitudes of family communication approaches for a Canadian cohort.
Ho A; Leach E; Virani A; Arbour L; Bartels K; Wong EK
J Genet Couns; 2022 Jun; 31(3):815-828. PubMed ID: 35032083
[TBL] [Abstract][Full Text] [Related]
25. An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations.
Ratnayake P; Wakefield CE; Meiser B; Suthers G; Price MA; Duffy J; ; Tucker K
Fam Cancer; 2011 Mar; 10(1):97-105. PubMed ID: 20878485
[TBL] [Abstract][Full Text] [Related]
26. How to inform relatives at risk of hereditary diseases? A mixed-methods systematic review on patient attitudes.
van den Heuvel LM; Smets EMA; van Tintelen JP; Christiaans I
J Genet Couns; 2019 Oct; 28(5):1042-1058. PubMed ID: 31216099
[TBL] [Abstract][Full Text] [Related]
27. Sharing genetic test results in Lynch syndrome: communication with close and distant relatives.
Stoffel EM; Ford B; Mercado RC; Punglia D; Kohlmann W; Conrad P; Blanco A; Shannon KM; Powell M; Gruber SB; Terdiman J; Chung DC; Syngal S
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):333-8. PubMed ID: 18258490
[TBL] [Abstract][Full Text] [Related]
28. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.
Schwartz MD; Peshkin BN; Hughes C; Main D; Isaacs C; Lerman C
J Clin Oncol; 2002 Jan; 20(2):514-20. PubMed ID: 11786581
[TBL] [Abstract][Full Text] [Related]
29. Patients' Perceptions of Their Relatives' Risk of Developing Rheumatoid Arthritis and of the Potential for Risk Communication, Prediction, and Modulation.
Falahee M; Simons G; Buckley CD; Hansson M; Stack RJ; Raza K
Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1558-1565. PubMed ID: 27998043
[TBL] [Abstract][Full Text] [Related]
30. Life after BRCA1/2 testing: family communication and support issues.
DeMarco TA; McKinnon WC
Breast Dis; 2006-2007; 27():127-36. PubMed ID: 17917144
[TBL] [Abstract][Full Text] [Related]
31. End-of-life care in the intensive care unit: a patient-based questionnaire of intensive care unit staff perception and relatives' psychological response.
Hartog CS; Schwarzkopf D; Riedemann NC; Pfeifer R; Guenther A; Egerland K; Sprung CL; Hoyer H; Gensichen J; Reinhart K
Palliat Med; 2015 Apr; 29(4):336-45. PubMed ID: 25634628
[TBL] [Abstract][Full Text] [Related]
32. To tell or not to tell: barriers and facilitators in family communication about genetic risk.
Forrest K; Simpson SA; Wilson BJ; van Teijlingen ER; McKee L; Haites N; Matthews E
Clin Genet; 2003 Oct; 64(4):317-26. PubMed ID: 12974737
[TBL] [Abstract][Full Text] [Related]
33. Family communication following a diagnosis of myotonic dystrophy: To tell or not to tell?
Taylor S; Rodrigues M; Poke G; Wake S; McEwen A
J Genet Couns; 2019 Oct; 28(5):1029-1041. PubMed ID: 31385417
[TBL] [Abstract][Full Text] [Related]
34. Attitudes Toward Return of Genetic Research Results to Relatives, Including After Death: Comparison of Cancer Probands, Blood Relatives, and Spouse/Partners.
Radecki Breitkopf C; Wolf SM; Chaffee KG; Robinson ME; Lindor NM; Gordon DR; Koenig BA; Petersen GM
J Empir Res Hum Res Ethics; 2018 Jul; 13(3):295-304. PubMed ID: 29701109
[TBL] [Abstract][Full Text] [Related]
35. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.
Bakos AD; Hutson SP; Loud JT; Peters JA; Giusti RM; Greene MH
Health Expect; 2008 Sep; 11(3):220-31. PubMed ID: 18816319
[TBL] [Abstract][Full Text] [Related]
36. Communication Between Breast Cancer Patients Who Received Inconclusive Genetic Test Results and Their Daughters and Sisters Years After Testing.
Baars JE; Ausems MG; van Riel E; Kars MC; Bleiker EM
J Genet Couns; 2016 Jun; 25(3):461-71. PubMed ID: 26446011
[TBL] [Abstract][Full Text] [Related]
37. Modes of responsibility in disclosing cancer genetic test results to relatives: An analysis of Swiss and Korean narrative data.
Aceti M; Caiata-Zufferey M; Pedrazzani C; Schweighoffer R; Kim SY; Baroutsou V; Katapodi MC; Kim S;
Patient Educ Couns; 2024 Jun; 123():108202. PubMed ID: 38395023
[TBL] [Abstract][Full Text] [Related]
38. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
[TBL] [Abstract][Full Text] [Related]
39. Patients' resistance to risk information in genetic counseling for BRCA1/2.
Gurmankin AD; Domchek S; Stopfer J; Fels C; Armstrong K
Arch Intern Med; 2005 Mar; 165(5):523-9. PubMed ID: 15767527
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Follow-Up Study on the Uptake of Genetic Counseling and Predictive DNA Testing in Inherited Cardiac Conditions.
van den Heuvel LM; van Teijlingen MO; van der Roest W; van Langen IM; Smets EMA; van Tintelen JP; Christiaans I
Circ Genom Precis Med; 2020 Oct; 13(5):524-530. PubMed ID: 33079600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
